Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by McCracken Joseph S, Director. Officer active across 5 companies, notably LUMOS PHARMA, INC.. In total, 12 filings have been logged. Split: 5 buys · 0 sell. Total volume traded: €169k. History available since 20 May 2021. The latest transaction was disclosed on 16 February 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to McCracken Joseph S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Joseph S McCracken is Administrateur at Savara Inc, Lumos Pharma, INC. and Nexvet Biopharma plc. He has 12 filings in total, and across the 12 recent filings included here, the activity is mainly acquisitions, with EUR 168861 of buys and EUR 0 of sells between 2016-01-05 and 2026-02-17.